This bill requires that each dietary supplement marketed in the United States be listed with the Secretary (the Food and Drug Administration). The responsible person (manufacturer, packer, or distributor) or a U.S. agent for a foreign responsible person must submit specified information for each product. Required information includes product name and statement of identity, a copy of the label, the full ingredient list and amounts per serving, number of servings per container, directions for use, warnings and allergen statements, product form (tablet, capsule, powder, etc.), contact information for the responsible person or U.S. agent, and any label claims. Amounts of ingredients included within a proprietary blend must be submitted but will remain confidential and not be publicly disclosed. The Secretary will provide a dietary supplement product listing number for each listed product and must establish a publicly searchable electronic database within two years that contains submitted information except certain confidential fields. The bill also amends the misbranding provision so failure to file or update required listings or provide requested information can cause a product to be considered misbranded.
For consumers: The bill would make label copies and many product details searchable in a public database, and products would display a product listing number on the label after specified dates. Confidential business information and the identity or location of certain facilities would not be made public.
For manufacturers and distributors: The responsible person must submit detailed product information, reserve or receive a product listing number, update listings when labels change, notify the Secretary when a product is discontinued, and provide addresses of manufacturing or sourcing locations on request. Existing products offered in interstate commerce by January 1, 2027 must be listed within 18 months after enactment; labels must include the product listing number beginning two years after enactment. New products must be listed at the time they are introduced into interstate commerce.
The bill authorizes $7,872,984 for fiscal year 2026 and $6,615,000 for each of fiscal years 2027 through 2030 to support activities under the new listing requirement and to hire needed personnel. The Secretary must establish the public electronic database within two years of enactment.
The bill states its purpose is to improve transparency and the availability of information regarding dietary supplements by creating a product listing requirement, issuing product listing numbers, and providing a publicly searchable database. It includes funding to carry out those activities.
No publicly available information.